Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

8272	Companies
113735	Keywords
54651	Articles
62053	Press releases

Home
Companies
Biophytis

BRIEF

published on 09/30/2024 at 23:05, 1 month 18 days ago

Biophytis publie ses comptes semestriels et annonce des avancées stratégiques

Biophytis Financement Finances 2024 Programme OBA Accord Blanver
BRIEF

published on 09/30/2024 at 23:05, 1 month 18 days ago

Biophytis Reports First-Half Financial Results and Updates on Business Activities

Financial Results Biophytis Clinical Trials Obesity Treatment Partnerships
PRESS RELEASE

published on 09/30/2024 at 23:00, 1 month 18 days ago

Biophytis publie ses comptes semestriels et fait le point sur ses activités
Biophytis publie ses comptes semestriels et fait le point sur ses activités. La société présente ses résultats financiers pour le premier semestre 2024 et annonce les prochaines étapes de développement de ses programmes cliniques

Biophytis Partenariat BIO101 Obésité Comptes Semestriels
PRESS RELEASE

published on 09/30/2024 at 23:00, 1 month 18 days ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights

Financial Results Biophytis Licensing Agreement Business Activities Obesity Program
REGULATED PRESS RELEASE

published on 09/30/2024 at 23:00, 1 month 18 days ago

Biophytis publie ses comptes semestriels et fait le point sur ses activités
Biophytis publie ses résultats semestriels 2024, annonce son programme OBA dans l'obésité et un accord avec Blanver pour l'Amérique Latine

Résultats Semestriels Biophytis Biotechnologie Programme OBA Accord Blanver
REGULATED PRESS RELEASE

published on 09/30/2024 at 23:00, 1 month 18 days ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America

Financial Results Biophytis Latin America BIO101 OBA Program
BRIEF

published on 07/22/2024 at 08:17, 3 months 27 days ago

Biophytis Enters Asia Market with Strategic Partnerships

Biophytis Pharmaceutical Partnerships Market Expansion Asia
BRIEF

published on 07/22/2024 at 08:17, 3 months 27 days ago

Biophytis entre sur le marché asiatique avec des partenariats stratégiques

Biophytis Partenariats Asie L'expansion Du Marché Pharmaceutique
PRESS RELEASE

published on 07/22/2024 at 08:12, 3 months 27 days ago

Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
Biophytis signs partnership contracts with local agents in Asia to accelerate deployment of BIO101 drug candidate, targeting age-related diseases in key markets like Japan and China

Biophytis Partnership Asia Age-related Diseases BIO101
PRESS RELEASE

published on 07/22/2024 at 08:12, 3 months 27 days ago

Biophytis déploie sa stratégie de partenariats et signe deux contrats avec des agents locaux en Asie
Biophytis déploie sa stratégie de partenariats en Asie en signant deux contrats avec des agents locaux. Objectif : accélérer le déploiement du candidat-médicament BIO101 dans la région

Biophytis Partenariats Asie BIO101 Agents Locaux

Accesswire

Published on 11/19/2024 at 00:10, 30 minutes ago

Rockland Resources Announces Proposed Share Consolidation
Published on 11/19/2024 at 00:10, 30 minutes ago

Gungnir Resources Announces AGM Results
Published on 11/19/2024 at 00:00, 40 minutes ago

PPX Subscribes Equipment Construction Agreement
Published on 11/18/2024 at 23:35, 1 hour 5 minutes ago

Alset AI Appoints Accomplished Executive Adam Ingrao as Chief Executive Officer
Published on 11/18/2024 at 23:30, 1 hour 10 minutes ago

CUCKOO Unveils Best Black Friday Deals Across Multiple Platforms

View all ACCESSWIRE

EQS Group

Published on 11/18/2024 at 20:12, 4 hours 28 minutes ago

EQS-Adhoc: aap Implantate AG: EBITDA guidance raised
Published on 11/18/2024 at 20:04, 4 hours 36 minutes ago

Further postponement of the publication of the 2023 annual financial statements
Published on 11/18/2024 at 19:00, 5 hours 40 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 11 NOVEMBRE 2024 au 15 NOVEMBRE 2024
Published on 11/18/2024 at 18:54, 5 hours 46 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/18/2024 at 18:10, 6 hours 30 minutes ago

Freelance.com: 3rd quarter revenues

Les Echos

Published on 11/18/2024 at 20:00, 4 hours 40 minutes ago

Louis Hachette Group confirms its dividend policy ahead of listing on Euronext Growth (Paris)
Published on 11/18/2024 at 20:00, 4 hours 40 minutes ago

Louis Hachette Group confirme sa politique de dividende en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/18/2024 at 18:30, 6 hours 10 minutes ago

ICADE – CP - Standard & Poor’s abaisse la notation de crédit long terme du Groupe à BBB perspective stable
Published on 11/18/2024 at 18:30, 6 hours 10 minutes ago

ICADE – PR - Standard & Poor’s lowers the Group’s long-term credit rating to BBB with a stable outlook
Published on 11/18/2024 at 17:45, 6 hours 55 minutes ago

NFL BIOSCIENCES : LE MÉCANISME D’ACTION NOUVEAU ET DISRUPTIF DE NFL-101 POUR LE SEVRAGE TABAGIQUE PRÉSENTÉ AU CONGRÈS ANNUEL DE LA SOCIÉTÉ FRANCOPHONE DE TABACOLOGIE

View all LES ECHOS COMFI WIRE